Home › Ovarian Cancer
Ovarian Cancer clinical trials recruiting in the U.S.
263 studies for Ovarian Cancer are recruiting participants at sites across the United States.
Ovarian cancer is a cancerous tumor that forms in the tissues of an ovary. The ovaries are a pair of female reproductive glands that make eggs and female hormones.
Cities with the most studies
- Houston, TX89 studies
- New York City, NY69 studies
- Boston, MA61 studies
- Los Angeles, CA50 studies
- Nashville, TN49 studies
- Arlington, VA46 studies
- Philadelphia, PA44 studies
- Columbus, OH39 studies
- St. Louis, MO38 studies
- Chicago, IL36 studies
- San Antonio, TX31 studies
- Cleveland, OH30 studies
- Pittsburgh, PA30 studies
- Seattle, WA30 studies
- Atlanta, GA29 studies
- Rochester, MN29 studies
- Dallas, TX28 studies
- Oklahoma City, OK28 studies
- Queens, NY28 studies
- Durham, NC27 studies
- Portland, OR27 studies
- Detroit, MI26 studies
- Aurora, CO25 studies
- Baldwin Park, CA25 studies
- Minneapolis, MN24 studies
- San Diego, CA24 studies
- Grand Rapids, MI24 studies
- Birmingham, AL23 studies
- Washington, DC23 studies
- Miami, FL23 studies
- Orlando, FL22 studies
- Baltimore, MD22 studies
- New Haven, CT21 studies
- Tampa, FL21 studies
- Edison, NJ20 studies
- Salt Lake City, UT19 studies
- Cincinnati, OH19 studies
- Mountain View, CA19 studies
- San Francisco, CA19 studies
- Milwaukee, WI17 studies
By state
- Alabama27 studies
- Alaska7 studies
- Arizona26 studies
- Arkansas11 studies
- California105 studies
- Colorado44 studies
- Connecticut28 studies
- Delaware5 studies
- District of Columbia7 studies
- Florida81 studies
- Georgia35 studies
- Hawaii7 studies
- Idaho4 studies
- Illinois49 studies
- Indiana23 studies
- Iowa10 studies
- Kansas10 studies
- Kentucky25 studies
- Louisiana19 studies
- Maine9 studies
- Maryland40 studies
- Massachusetts67 studies
- Michigan50 studies
- Minnesota53 studies
- Mississippi6 studies
- Missouri41 studies
- Montana10 studies
- Nebraska15 studies
- Nevada11 studies
- New Hampshire4 studies
- New Jersey40 studies
- New Mexico16 studies
- New York96 studies
- North Carolina44 studies
- North Dakota7 studies
- Ohio70 studies
- Oklahoma31 studies
- Oregon34 studies
- Pennsylvania69 studies
- Rhode Island16 studies
- South Carolina17 studies
- South Dakota16 studies
- Tennessee55 studies
- Texas122 studies
- Utah29 studies
- Virginia57 studies
- Washington38 studies
- West Virginia10 studies
- Wisconsin29 studies
Recently updated studies
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
RecruitingPhase 2
All ages · All sexes · Updated Oct 2, 2026 · NCT05564377The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
RecruitingPhase 1/2
Ages 12 and older · All sexes · Updated Oct 2, 2026 · NCT04585750Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
RecruitingObservational study
Ages 2 to 100 · All sexes · Updated Oct 2, 2026 · NCT01950572Distance-Based Exercise to Preserve Function and Prevent Disability
Recruiting
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT07059884A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT06465069Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies
RecruitingPhase 1
Ages 18 to 120 · All sexes · Updated Oct 2, 2026 · NCT04847063Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma
RecruitingPhase 1
Ages 18 to 120 · All sexes · Updated Oct 2, 2026 · NCT06885697A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT06270706Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RecruitingObservational study
Ages 3 and older · All sexes · Updated Oct 2, 2026 · NCT01441089Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer
RecruitingPhase 2
Ages 18 to 72 · All sexes · Updated Oct 2, 2026 · NCT01174121A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT06760819A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
RecruitingPhase 1
Ages 19 and older · All sexes · Updated Oct 1, 2026 · NCT06586957A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
RecruitingPhase 2
Ages 18 and older · Women · Updated Oct 1, 2026 · NCT07024784A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT06172478177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT07189871TLR9 Immunotherapy for Peritoneal Carcinomatosis
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT07658196Torvutatug Samrotecan Plus Bevacizumab as First-line Maintenance in Homologous Recombination Deficiency (HRD) Negative Advanced Epithelial Ovarian Cancer
RecruitingPhase 3
Ages 18 and older · Women · Updated Oct 1, 2026 · NCT07851025Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients
Recruiting
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT04751435The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT07285044A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Other Anticancer Drugs in Adult Participants With Ovarian Cancer
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT07278336A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT07814248Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 29, 2026 · NCT07360314First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, as Monotherapy and in Combination With Anticancer Therapy in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 29, 2026 · NCT06799065A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 29, 2026 · NCT05877599A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
RecruitingPhase 2
Ages 18 and older · Women · Updated Sep 29, 2026 · NCT05128825From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.